Glioblastoma is a aggressive brain cancer known for its quick growth and unresponsiveness to conventional treatments. Investigations are constantly underway to identify new treatment strategies, and recently, a unique biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatmen